FilingFirehose · free AI preview
MYRIAD GENETICS INC
MYGN · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Officer Departure
Myriad Genetics (MYGN) reported an officer departure on June 4, 2026, according to Form 8-K Section 5.02 filing. No cyber incidents were detected in the past 90 days, though leadership transitions can signal underlying operational or strategic shifts worth examining. The full $49 Report extends the analysis window to 12 months, quantifies dilution risk from equity compensation and secondary offerings, maps financing history, and flags AI-related exposure in genomics operations. The full $49 Report adds executive departure context, dilution trajectory scoring, and capital structure risk assessment.
Want the full 5-section $49 Report on MYGN?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.